2024 Annual Public Meeting of the Board of Directors

May 7, 2024

12:30pm-2pm (eastern)
(in-person and virtual attendance options)

CaliffEach year, the Reagan-Udall Foundation for the FDA conducts an annual public meeting to discuss its activities in support of the U.S. Food and Drug Administration.

The Foundation’s annual public meeting provides an opportunity for engagement between FDA and external stakeholders including patients and consumer advocates, regulated industry, health care providers, academics, and others dedicated to improving America's public health.

This year, attendees will be able to hear from Commissioner Robert M. Califf, MD, MACC, and several key agency leaders. The meeting will include a town hall-style discussion with an opportunity for attendees to submit questions. This is a hybrid event with options to attend virtually or in-person at Foundation headquarters at 1333 New Hampshire Ave. NW, Washington, DC (limited seating available).

See the Full Agenda

FDA Speakers

Register to Attend Virtually
Register to Attend In-Person

Agenda

12:30PM

Welcome and Opening Remarks

Richard L. Schilsky, MD, FDA Foundation Board Chair
Susan C. Winckler, RPh, Esq., FDA Foundation CEO

12:40PM

FDA Priorities Panel Discussion

Moderated by Susan C. Winckler, RPh, Esq.

Jim Jones, MS, Deputy Commissioner for Human Foods, U.S. Food and Drug Administration
Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration
Marta Sokolowska, PhD, Deputy Center Director, Substance Use and Behavioral Health, U.S. Food and Drug Administration
Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration
Michele Mital, Deputy Director, Center for Tobacco Products, U.S. Food and Drug Administration
Tracey Forfa, JD, M Div, Director, Center of Veterinary Medicine, U.S. Food and Drug Administration
Douglas Stearn, JD, Deputy Associate Commissioner for Regulatory Affairs, U.S. Food and Drug Administration

1:30PM

Commissioner Remarks with Q&A

Robert M. Califf, MD, MACC, Commissioner of Food and Drugs, U.S. Food and Drug Administration

1:55PM

Conclude